ERBB2 and non-small cell lung carcinoma: So far, the NCCN guidelines recommend a panel of genetic tests for NSCLC including EGFR, ALK, ROS1, BRAF, MET, RET, ERBB2, and KRAS. Multigene targeted sequencing is quick and economical lab test to provide a comprehensive spectrum of tumor tissue mutations.